Episode 126

full
Published on:

20th Jun 2023

Sonoma Pharmaceuticals, Inc. (SNOA) Amy Trombly, CEO

Sonoma Pharmaceuticals

is a global healthcare leader for developing and producing stabilized

hypochlorous acid (HOCl) products for a wide range of applications, including

wound care, eye care, nasal care, oral care, dermatological conditions, animal

health care and non-toxic disinfectants. The company's products reduce

infections, itch, pain, scarring and harmful inflammatory responses in a safe

and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl)

show it to have impressive antipruritic, antimicrobial, antiviral and

anti-inflammatory properties. Sonoma's stabilized HOCl immediately relieves

itch and pain, kills pathogens and breaks down biofilm, does not sting or

irritate skin, and oxygenates the cells in the area treated, assisting the body

in its natural healing process. The company's products are sold either directly

or via partners in 55 countries worldwide.

Show artwork for The Wall Street Resource

About the Podcast

The Wall Street Resource
Your resource for microcap discovery and due diligence
As part of the investment process, we have conducted countless CEO and executive interviews, and found this to be an invaluable use of time. We provide The Wall Street Resource, not only to help you leverage your time, but for discovery and a starting point for due diligence.

About your host

Profile picture for Jeffrey Kone

Jeffrey Kone

Managing Member and portfolio manager of a micro-cap fund for over 15 years. Securities experience that encompasses almost all aspects of the industry (buy side, sell side, retail, institutional and investment banking). Degree from University of Southern California with a Bachelor of Science in Business, emphasis in Entrepreneurship.